Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06604299 · ClinicalTrials.gov registry record · NA

Digital Mindfulness Meditation-enhanced Cognitive Behavioral Therapy (CBT-MM) for Binge Eating Disorder

A NA study, sponsored by Yeshiva University.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT06604299: Completed NA study, sponsored by Yeshiva University.

NCT06604299 is a NA study that has completed, run by Yeshiva University. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06604299, a NA study, has completed, sponsored by Yeshiva University.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The investigators will evaluate the acceptability and feasibility of a 18-week long digital mindfulness-based and cognitive behavioral therapy intervention for binge eating disorder. This study is a prospective single-arm trial during the intervention development phase. Following this phase, after the intervention has been further developed, a subsequent study (with a different clinicaltrials.gov identification #) will utilize a randomized control trial design.

Primary Outcome

Single-items measuring dimensions of acceptability, including overall satisfaction, engagement, visual appeal of content, understandability of program material, desire to continue the program, and overall helpfulness. Scores for each item range from 1 to 5, , with higher scores indicating better acceptability.

Interventions

  • BEHAVIORAL Meditation-enhanced Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2024-10-01
Est. Completion 2025-05-01
Phase NA
Yeshiva University

7 total trials

What the finished NCT06604299 record still lists

NCT06604299 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Meditation-enhanced Cognitive Behavioral Therapy is the first listed.

NCT06604299 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06604299 about?

NCT06604299 is a clinical study titled "Digital Mindfulness Meditation-enhanced Cognitive Behavioral Therapy (CBT-MM) for Binge Eating Disorder". The investigators will evaluate the acceptability and feasibility of a 18-week long digital mindfulness-based and cognitive behavioral therapy intervention for binge eating disorder. This study is a prospective single-arm trial during the intervention development phase. Following this phase, after ...

What is the current status of trial NCT06604299?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-10-01. Estimated completion is 2025-05-01.

What interventions are being tested in trial NCT06604299?

The interventions under investigation include: Meditation-enhanced Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06604299?

This trial is sponsored by Yeshiva University, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06604299's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06604299, the US trial registry maintained by the National Library of Medicine. NCT06604299 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.